NM_139057.4:c.1075+27340C>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_139057.4(ADAMTS17):c.1075+27340C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.566 in 151,910 control chromosomes in the GnomAD database, including 24,592 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.57 ( 24592 hom., cov: 32)
Consequence
ADAMTS17
NM_139057.4 intron
NM_139057.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.04
Publications
0 publications found
Genes affected
ADAMTS17 (HGNC:17109): (ADAM metallopeptidase with thrombospondin type 1 motif 17) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. [provided by RefSeq, May 2016]
ADAMTS17 Gene-Disease associations (from GenCC):
- Weill-Marchesani 4 syndrome, recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADAMTS17 | ENST00000268070.9 | c.1075+27340C>A | intron_variant | Intron 7 of 21 | 1 | NM_139057.4 | ENSP00000268070.4 | |||
| ADAMTS17 | ENST00000568565.2 | c.1075+27340C>A | intron_variant | Intron 7 of 22 | 5 | ENSP00000456161.2 | ||||
| ADAMTS17 | ENST00000378898.8 | n.756+27340C>A | intron_variant | Intron 6 of 14 | 2 | |||||
| ADAMTS17 | ENST00000559976.1 | n.71+27340C>A | intron_variant | Intron 2 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.566 AC: 85958AN: 151792Hom.: 24580 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
85958
AN:
151792
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.566 AC: 86002AN: 151910Hom.: 24592 Cov.: 32 AF XY: 0.563 AC XY: 41808AN XY: 74254 show subpopulations
GnomAD4 genome
AF:
AC:
86002
AN:
151910
Hom.:
Cov.:
32
AF XY:
AC XY:
41808
AN XY:
74254
show subpopulations
African (AFR)
AF:
AC:
21957
AN:
41382
American (AMR)
AF:
AC:
7689
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1833
AN:
3470
East Asian (EAS)
AF:
AC:
2428
AN:
5166
South Asian (SAS)
AF:
AC:
3096
AN:
4806
European-Finnish (FIN)
AF:
AC:
5845
AN:
10554
Middle Eastern (MID)
AF:
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
AC:
41253
AN:
67958
Other (OTH)
AF:
AC:
1172
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1902
3803
5705
7606
9508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1892
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.